Psoriasis-related juvenile idiopathic arthritis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

5FDA treatments

8Recruiting trials

Regulatory Watchboard

10 events

Dec 2025Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.

Novartis Pharmaceuticals

TrialNOT YET RECRUITING

Sep 2025Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

Novartis Pharmaceuticals — PHASE1

TrialRECRUITING

Mar 2025A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Bristol-Myers Squibb — PHASE3

TrialRECRUITING

Mar 2025An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

UCB Biopharma SRL — PHASE3

TrialRECRUITING

Oct 2024A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Janssen Research & Development, LLC — PHASE3

TrialRECRUITING

Jul 2024A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

AbbVie — PHASE3

TrialRECRUITING

Mar 2023A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

Amgen — PHASE3

TrialRECRUITING

Aug 2022A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Janssen Research & Development, LLC — PHASE3

TrialACTIVE NOT RECRUITING

Mar 2022Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

Amgen — PHASE3

TrialRECRUITING

Apr 2021A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Eli Lilly and Company — PHASE3

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

2

Total programs

2

Open now

1

Copay cards

Copay Assistance1

Marbeta L Kit

Marnel

OpenContact for details

Patient Assistance Programs1

Rinvoq

AbbVie, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

5 FDA-approved

Enbrel

(etanercept)Orphan drugstandard

Immunex Corporation

Tumor Necrosis Factor Blocker [EPC]

12.1 Mechanism of Action TNF is a naturally occurring cytokine that is involved in normal inflammatory and immune responses. It plays an important rol...

SIMPONI ARIAï¿½

(golimumab)Orphan drugstandard

Janssen Research & Development, LLC

Tumor Necrosis Factor Blocker [EPC]

12.1 Mechanism of Action Golimumab is a human monoclonal antibody that binds to both the soluble and transmembrane bioactive forms of human TNFα. This...

OTEZLAï¿½

(apremilast)Orphan drugstandard

Amgen Inc.

Phosphodiesterase 4 Inhibitor [EPC]

12.1 Mechanism of Action Apremilast is an oral small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAM...

HUMIRA

(adalimumab)Orphan drugstandard

AbbVie, Inc.

12.1 Mechanism of Action Adalimumab binds specifically to TNF-alpha and blocks its interaction with the p55 and p75 cell surface TNF receptors. Adalim...

Remicade

(infliximab)Orphan drugstandard

Janssen Biotech, Inc.

Tumor Necrosis Factor Blocker [EPC]

12.1 Mechanism of Action Infliximab neutralizes the biological activity of TNFα by binding with high affinity to the soluble and transmembrane forms o...

View full treatment details on disease page →

Clinical Trial Landscape

8 active trials

7Phase 3

1Phase 1

8Total recruiting

Search clinical trials for Psoriasis-related juvenile idiopathic arthritis →

Recent News & Research

No recent news articles indexed yet for Psoriasis-related juvenile idiopathic arthritis.
Search PubMed for Psoriasis-related juvenile idiopathic arthritis →

Browse all Psoriasis-related juvenile idiopathic arthritis news →

Specialist Network

Top 2 by expertise

Michelle Batthish, MD

McMaster University

Megan L Fitzgerald, PhD

Brain Inflammation Collaborative

📍 Delafield, Wisconsin

View all Psoriasis-related juvenile idiopathic arthritis specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles